Absorption and metabolism of biologically active genistein derivatives in colon carcinoma cell line (CACO-2)

Acta Poloniae Pharmaceutica - Drug Research

Volumn 71, Issue 6, 2014, Pages 1037-1044

  Papaj, Katarzyna ^a   Rusin, Aleksandra ^b   Szeja, Wiesaw ^a   Grynkiewicz, Grzegorz ^c  

^a SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Caco 2; Genistein; LC MS MS; Metabolism

Indexed keywords

CARBONYL DERIVATIVE; GENISTEIN; GLUCURONIDE; SULFATE; ANTINEOPLASTIC AGENT;

ARTICLE; CHEMICAL MODIFICATION; COLON CARCINOMA; CYTOTOXICITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DISPOSITION; DRUG METABOLISM; DRUG PENETRATION; DRUG TRANSPORT; ELECTROSPRAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE ABSORPTION; LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; ABSORPTION; ANALOGS AND DERIVATIVES; CACO 2 CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; TANDEM MASS SPECTROMETRY; TRANSPORT AT THE CELLULAR LEVEL;

ABSORPTION, PHYSIOLOGICAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL PROLIFERATION; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GENISTEIN; HUMANS; MOLECULAR STRUCTURE; TANDEM MASS SPECTROMETRY;

EID: 84919951277     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Polkowski K., Mazurek A.P.: Acta Pol. Pharm. Drug Res. 57, 135 (2000).
2. Prasain J.K., Carlson S.H., Wyss J.M.: Maturitas 66, 163 (2010).
3. Kampa M., Nifli A.P., Notas G., Castanas E.: Rev. Physiol. Biochem. Pharmacol. 159, 79 (2007).
4. Middleton E., Kandaswami C., Theoharides T.C.: Pharmacol. Rev. 52, 673 (2000).
5. Polkowski K., PopioŁkiewicz J., KrzeczyÒski K., Ramza J., Pucko W., Zegrocka-Stendel O., Boryski J. et al.: Cancer Lett. 203, 59 (2004).
6. Rusin A., Krawczyk Z., Grynkiewicz G., Gogler A., Zawisza-PuchaŁka J., Szeja W.: Acta Biochim. Pol. 57, 23 (2010).
7. Rusin A., Zawisza-PuchaŁka J., Kujawa K., Gogler-Piglowska A., Wietrzyk J., ͆witalska M., GŁowala-KosiÒksa M. et al.: Bioorg. Med. Chem. Lett. 19, 259 (2011).
8. Byczek A., Zawisza-PuchaŁka J., Gruca A., Papaj K., Grynkiewicz G., Szeja W., Rusin A.: J. Chem. 2013, Article ID 191563 (2013).
9. Rusin A., Gogler A., GŁowala-KosiÒska M., Bochenek D., Gruca A., Grynkiewicz G., Zawisza J. et al.: Bioorg. Med. Chem. Lett. 19, 4939 (2009).
10. Wise C., in Epithelial Cell Culture Protocols, Tavelin S., GråSjö J., Taipalensuu G.O. Artursson P. Eds., p. 233, Humana Press, Totowa, New Jersey 2002.
11. Seera H., Mendes T., Bronze M. R., Simplicio L.: Bioorg. Med. Chem. 16, 4009 (2008).
12. Chen Y., Wang J., Wang L., Chen L., Wu Q.: Molecules 17, 14908 (2012).
13. Prasain J.K., Barnes S.: Mol. Pharm. 40, 846 (2007).
14. Shah P., Jogani V., Bagchi T., Misra A: Biotechnol. Prog. 22, 186 (2006).
15. Artursson P., Palm K., Luthman K: Adv. Drug Deliv. Rev. 22, 67 (1996).
16. Artursson P., Karlsson J.: Biochem. Biophys. Res. Commun. 175, 880 (1991).
17. Liu Y., Hu M.: Drug Metab. Dispos. 30, 370 (2002).
18. Kobayashi S., Shinohara M., Nagai T., Konishi Y.: Biosci. Biotechnol. Biochem. 77, 2210 (2013).
19. Faassen F., Vogel G., Spanings H., Vromans H.: Int. J. Pharm. 263, 113 (2003).